Additional Details
-
Tocilizumab in Lung Transplantation
University of Utah Medical Center (Site #: 71126)Salt Lake City UT. 84132View Details -
Tocilizumab in Lung Transplantation
Duke University Medical Center (Site #: 71139)Durham NC. 27710View Details -
Tocilizumab in Lung Transplantation
David Geffen School of Medicine at UCLA (Site #: 71123)Los Angeles CA. 90095View Details -
Tocilizumab in Lung Transplantation
Massachusetts General Hospital (Site #: 71107)Boston MA. 02114View Details -
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Saint John Regional Hospital-Horizon Health NetworkSaint John NB. E2L4L2View Details -
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Verspeeten Family Cancer Centre, London Health Sciences CentreLondon ON. N6A 5W9View Details -
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
BC-Cancer Agency - VancouverVancouver BC. V5Z 4E6View Details -
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Centre Hospitalier de l'Universite de Montreal (CHUM)Montreal QC. H2X 0A9View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Temple Health - OaksPhoenixville PA. 19460View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Temple University Hospital - Main CampusPhiladelphia PA. 19140View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteAurora CO. 80045View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteWashington D.C. DC. 20007View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SitePittsburgh PA. 15213View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteMiami FL. 33144View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteLos Angeles CA. 90301View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteJacksonville FL. 32610View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteNew York NY. 11201View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteDenison TX. 75020View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
GSK Investigational SiteEl Paso TX. 79902View Details
